Item
5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
The
employment with OccuLogix, Inc. (the “Company”) of Thomas P. Reeves, President
and Chief Operating Officer, ended as of the close of business on June 30,
2008. As disclosed in the Company’s preliminary proxy statement,
filed with the U.S. Securities and Exchange Commission on May 20, 2008, to
solicit proxies for the upcoming annual and special meeting of the Company’s
stockholders (the “Proxy Statement”), it had been contemplated that Mr. Reeves
would not continue employment with the Company.
Under his
employment agreement with the Company, upon termination of employment by the
Company without just cause, Mr. Reeves is entitled to receive a payment equal to
the aggregate of 24 months of his salary and bonus (which amount will equal the
average annual bonus earned by him during his employment with the Company), 2.5%
of his annual base salary in respect of benefits and U.S.$100,000 (the
“Severance Amount”). Mr. Reeves has agreed to postpone the date on
which the Severance Amount will become due and owing to him until the earliest
to occur of (i) September 1, 2008, (ii) the date on which the Company closes a
financing for total gross proceeds in an aggregate amount of at least
U.S.$5,000,000, whether by way of debt, equity or otherwise, and whether such
financing is effected in a single transaction or a series of related or
unrelated transactions, and (iii) a change of control of the
Company. In addition, Mr. Reeves has agreed to reduce the Severance
Amount by Cdn$8,568.29, being the aggregate amount that the Company disbursed on
his behalf, during 2008, for certain perquisites to which he was entitled under
his employment agreement with the Company. Subject to obtaining the
requisite approval of the Company’s stockholders of the proposed share reserve
increase under the Company’s 2002 Stock Option Plan (the “Stock Option Plan”)
which is described under the heading “Proposal IX” of the Proxy Statement (and
subject also to obtaining the requisite approval of the Company’s stockholders
of all of the other proposals conditioned on the proposed share reserve increase
under the Stock Option Plan), Mr. Reeves will be paid up to 50% of such modified
Severance Amount in stock options to be issued under the Stock Option
Plan. The balance of such modified Severance Amount will be paid in
cash.
As
described under the heading “Proposal VIII” of the Proxy Statement, subject to
obtaining the requisite approval of the Company’s stockholders therefor,
notwithstanding the termination of Mr. Reeves’ employment with the Company, the
Company has agreed to extend the respective terms of the time-based stock
options of the Company, held by Mr. Reeves, until the tenth anniversaries of
their respective dates of grant. Mr. Reeves holds an aggregate of
420,000 such stock options, of which (i) 300,000 were granted on December 16,
2004, (ii) 20,000 were granted on March 10, 2007 and (iii) 100,000 were granted
on July 3, 2007.
- 2
-
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly
caused this Report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
OCCULOGIX,
INC.
|
||
|
Date: July
2, 2008
|
By:
|
/s/Suh
Kim
|
|
Suh
Kim
|
||
|
General
Counsel
|
- 3 -